Shanghai, China · Founded 2020 · Privately Held (backing)
Researcher of immune cell drugs designed for tumour patients. Enkai Cell Technology is based in Shanghai, China and was founded in 2020. It has raised $28.9 million.
Last price · $/share
—
Implied valuation
—
Total raised
$28.9M
Last round
—
Cap table — not yet on record
Enkai Cell Technology's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Enkai Cell Technology with a free account
·The complete investor list: 11 names
·Watch Enkai Cell Technology: the Monday email on marks, rounds and moves
